"Esophageal squamous cell cancer" trang 1 - tải miễn phí từ tailieunhanh
Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project

Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project
12    84    1
High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma

High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma
10    58    1
Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma

Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma
8    54    1
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: A monocentric case-control study

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: A monocentric case-control study
7    111    1
TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
14    8    1
Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya

Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya
8    82    1
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: Results from a retrospective study

The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: Results from a retrospective study
11    58    1
Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma

Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma
12    53    1
Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma

Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma
7    42    1
Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma

Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma
11    56    1
Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma
10    55    1
Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
10    54    1
Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers
11    59    1
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
7    1    1
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma

The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma
14    2    1
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy

Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
9    52    1
The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment

The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment
12    2    1
Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma

Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma
11    5    1
Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis

Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
16    56    1
Decreased tumor suppressor candidate 3 predicts poor prognosis of patients with esophageal squamous cell carcinoma

Decreased tumor suppressor candidate 3 predicts poor prognosis of patients with esophageal squamous cell carcinoma
7    79    0